Vaginal ring to prevent HIV safe to use in late pregnancy and while breastfeeding

A vaginal ring used to prevent HIV infection is safe to use during late pregnancy and while breastfeeding, according to findings presented at a major international HIV conference in Seattle in the United States. The news comes as South Africa prepares for a likely national rollout of the ring and as more research confirms the safety of an HIV prevention pill during pregnancy. It is estimated that offering these products to pregnant and breastfeeding women could avert up to 136 000 new infections in roughly the next decade. Laura Lopez Gonzalez reports.

Read More

Women in Health: From test tubes to impacting lives – Dr Thesla Palanee-Phillips on making a difference with science

Dr Thesla Palanee-Phillips is the Director of Clinical Trials at the Wits Reproductive Health and HIV Institute (Wits RHI) at the University of the Witwatersrand. As part of Spotlight’s Women in Health series, Elri Voigt spoke to her about what set her off into a career in science, the significance of the ASPIRE trial that she co-chaired, and juggling motherhood and her career.

Read More

AIDS 2022: How to tailor HIV prevention efforts to people’s needs

One of the hot topics at the recently concluded AIDS 2022 conference held in Montreal, Canada, was how HIV prevention interventions such as pills or injections that prevent HIV infection should be made available to different groups of people. Tiyese Jeranji spoke to some local experts and an activist about the rich set of discussions.

Read More

Research round-up: 7 new HIV prevention options in the pipeline

One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV infection. Elri Voigt rounds up the HIV pre-exposure prophylaxis (PrEP) research presented at the recent International AIDS Society Conference, including a biodegradable antiretroviral implant.

Read More